Related references
Note: Only part of the references are listed.The changing epidemiology of hepatitis C virus infection in Europe
Juan I. Esteban et al.
JOURNAL OF HEPATOLOGY (2008)
Current therapy for hepatitis C
Mireen Friedrich-Rust et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Impaired health-related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels
M. von Wagner et al.
JOURNAL OF VIRAL HEPATITIS (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Calculating QALYs, comparing QALY and DALY calculations
Franco Sassi
HEALTH POLICY AND PLANNING (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C
A Hollander et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection
Carolyn A. Lang et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Management of end stage liver disease (ESLD): What is the current role of orthotopic liver transplantation (OLT)?
JM Miro et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatitis C - Cost of illness and considerations for the economic evaluation of antiviral therapies
John B. Wong
PHARMACOECONOMICS (2006)
Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: A health technology assessment commissioned by the German Federal Ministry of Health and Social Security
U Siebert et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2005)
Different seroprevalence and molecular epidemiology patterns of hepatitis c virus infection in Italy
F Ansaldi et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C
M Buti et al.
JOURNAL OF HEPATOLOGY (2005)
Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment
BMR Spiegel et al.
HEPATOLOGY (2005)
The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases
E Sagnelli et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Global burden of disease (GBD) for hepatitis C
Y Hutin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Evolution of liver transplantation in Europe: Report of the European liver transplant registry
P Adam et al.
LIVER TRANSPLANTATION (2003)
Projecting future complications of chronic hepatitis C in the United States
GL Davis et al.
LIVER TRANSPLANTATION (2003)
Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection
A Alberti et al.
ANNALS OF INTERNAL MEDICINE (2002)
The prevalence of hepatitis C in England and Wales
MA Balogun et al.
JOURNAL OF INFECTION (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Evaluation of hepatitis C surveillance in Poland in 1998
J Mazurek et al.
EPIDEMIOLOGY AND INFECTION (2002)
Simulation of hepatitis C based on a mandatory reporting system
M Sagmeister et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Medical progress: Hepatitis C virus infection.
GM Lauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Prevalence of hepatitis C virus infection in the general population of northern Spain
S Riestra et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
Prevalence of markers for hepatitis A, B and C in the german population. Results of the German National Health Interview and Examination Survey 1998
W Thierfelder et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2001)
Prevalence of hepatitis C infection among general practice patients in the Lyon area, France
P Pradat et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2001)
Emerging infectious diseases in Russia, 1990-1999
SV Netesov et al.
EMERGING INFECTIOUS DISEASES (2001)
Estimating future hepatitis C morbidity, mortality, and costs in the United States
JB Wong et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
Prediction of hepatitis C burden in Canada
SM Zou et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2000)
Epidemiology of hepatitis C virus infection in seven European Union countries:: a critical analysis of the literature
S Touzet et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
HJ Alter et al.
SEMINARS IN LIVER DISEASE (2000)
Share Paper
